Halozyme Inc. - Wutah pendapatan kuartal marang kuartal HALO

HALO (Halozyme) - tandha merek perusahaan

Halozyme Therapeutics (HALO) maintains a stable cash flow based on the licensing of drug delivery systems that create patent dependency for its partners. Quarterly revenue dynamics confirm this trend, where 38.40 represents the latest level. The monopolistic growth in enzyme sales improves comfort for oncology patients, while the utilization of external CRO and CMO organizations eliminates the costs of maintaining proprietary manufacturing plants.

Halozyme Corp (HALO) - Dinamika pendapatan kuartal marang kuartal saka 04.07.2022 nganti 21.11.2026

HALO (Halozyme): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:Halozyme Therapeutics - HALO
Produk seri halozyme.com

Halozyme Therapeutics (HALO) monetizes its unique subcutaneous drug delivery technology through a royalty system from the largest pharmaceutical behemoths. The dynamics of these inflows are quantified by comparing current quarterly revenue with the same period last year. This indicator measures the pace of business expansion, reflecting the company's real value. By analyzing the quarterly revenue growth percentage, an investor can identify the gap between fundamental success and inflated market expectations.

Perusahaan pesaing

BeiGene Oncology - Wutah pendapatan triwulanan|RVMD: Wutah pendapatan kuartal marang kuartal|AAPG: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal CG Oncology Inc (CGON)|URGN (urogen.com) - Wutah pendapatan triwulanan|BCAX: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Personalis (PSNL)|Wutah pendapatan triwulanan Erasca (ERAS)|Wutah pendapatan triwulanan DCTH (Delcath Systems)|Tambahing pendapatan triwulanan YMAB|AURA - Wutah pendapatan kuartal marang kuartal|candeltx.com - Owah-owahan dodolan kuartal marang kuartal|ARAY: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Citius Oncology Inc. (CTOR)|Wutah pendapatan kuartal marang kuartal TuHURA (HURA)|TARA - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Tingkat wutah pendapatan sajrone kuartal|TScan - Wutah pendapatan triwulanan|Champions Oncology, Inc. (CSBR) - Wutah dodolan triwulanan|XBIT (XBiotech Inc.) - Wutah dodolan triwulanan|CEL-SCI Corporation (CVM) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal OS Therapies|RADX: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal artivabio.com (ARTV)|Tingkat wutah dodolan sajrone kuartal Adlai Nortye|Wutah pendapatan triwulanan VERU (Veru Corporation)|Owah-owahan dodolan kuartal marang kuartal TPST (Tempest Tx)|XLO: Wutah dodolan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)